Skip to Content
  • 3.8
    Impact Factor
  • 6.9
    CiteScore
  • 21 days
    Submission to First Decision
  • 3 days
    Acceptance to Publication

Diagnostics

Diagnostics is an international, peer-reviewed, open access journal on medical diagnosis published semimonthly online by MDPI. The British Neuro-Oncology Society (BNOS), the International Society for Infectious Diseases in Obstetrics and Gynaecology (ISIDOG) and the Swiss Union of Laboratory Medicine (SULM) are affiliated with Diagnostics and their members receive a discount on the article processing charges.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, Inspec, CAPlus / SciFinder, and other databases.
  • Journal Rank: JCR - Q1 (Medicine, General and Internal) / CiteScore - Q1 (Internal Medicine)
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 20.4 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the first half of 2026).
  • Recognition of Reviewers: Reviewers whose reports are timely and of high quality receive an APC discount voucher for a future publication in an MDPI journal. Become a reviewer.
  • Companion journals for Diagnostics include: LabMed and AI in Medicine.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (20,950)

  • Article
  • Open Access

Background/Objectives: The relationship between circulating homocysteine (Hcy) and ocular microvascular alterations in pseudoexfoliation syndrome (PXS) remains unclear. This study evaluated the association between plasma Hcy concentrations and peripapillary vessel density (VD) in patients with PXS without clinically evident glaucoma and controls. Methods: This single-center, cross-sectional observational study with prospective recruitment included three groups: patients with PXS and Hcy < 15 µmol/L, patients with PXS and Hcy ≥ 15 µmol/L, and controls without PXS. Fasting plasma Hcy was measured using chemiluminescent immunoassay. Peripapillary VD was quantified from optical coherence tomography angiography images using ImageJ (version 1.54, National Institutes of Health, Bethesda, MD, USA). Generalized estimating equations accounted for inter-eye correlation and assessed associations adjusted for age, intraocular pressure, and PXS status. PXS-only and single-eye sensitivity analyses were performed. Results: VD analyses included 71 eyes from 60 participants. Mean peripapillary VD was 62.3 ± 7.2%, 54.1 ± 6.4%, and 66.3 ± 6.3% in the respective groups (overall p < 0.001). In the full cohort, each 1 µmol/L increase in Hcy was associated with a 0.30-percentage-point decrease in VD (95% CI, −0.57 to −0.03; p = 0.029). Associations remained inverse but were not statistically significant in the PXS-only analysis (B = −0.25; p = 0.114) or single-eye sensitivity analysis (B = −0.28; p = 0.077). Global retinal nerve fiber layer thickness did not differ significantly among groups. Conclusions: Higher plasma Hcy was associated with lower peripapillary VD in the full cohort, but evidence within PXS remained inconclusive. These exploratory cross-sectional findings do not establish causality or prognostic value and require confirmation in larger longitudinal studies.

Diagnostics

18 November 2026

Representative image-processing workflow for peripapillary superficial vascular complex (pSVC) optical coherence tomography angiography (OCTA) images. (A) Original en face OCTA image of the right eye. (B) Image cropped to 938 × 938 pixels and centered on the optic disc. (C) Binarization using Otsu’s thresholding method. (D) Selection of the peripapillary annular region of interest. (E) Division of the annular region into superior, inferior, nasal, and temporal sectors.
  • Article
  • Open Access

Background/Objectives: Qualitative complete blood count (CBC) profiles, formed by classifying each result relative to its reference interval, underlie rule-based interpretation and autoverification. The structure of the resulting profile space has not been characterised. Methods: We analysed 729,469 adult CBC records from 414,907 patients (14 analytes; Sysmex XN-10; January 2024–May 2025). The results were coded into five ordinal states relative to each record’s reference interval. We measured concentration, diversity, algebraic dependence and unobserved richness under three reference interval frameworks and at the patient level. Results: Under the laboratory’s limits, the records formed 40,376 distinct profiles. Seven profiles covered half of the records; the all-normal profile covered 42.2%. Removing four algebraically dependent analytes contracted the observed space by 63.0%; their discretised states were not fully determined by the other analytes. New profiles kept appearing, so the tail of the distribution remained open: with the framework held constant, 3.03% of the 2025 records carried a profile that was unseen in 2024 (predicted, 3.06%). Across the frameworks, the number of profiles varied 1.65-fold, but the concentrated head (a few profiles covering most records), the open tail and the contraction (52.3–63.0%) persisted. With one record per patient, the concentration was higher and the tail remained open. Conclusions: In this corpus, the reference framework changed the coordinates of the profile space (the number of profiles and the all-normal share) but not its structural properties. These properties suggest hypotheses for the design of rule-based interpretation systems.

Diagnostics

18 November 2026

(a)  Cumulative coverage of records by the most frequent profiles. (b) Rank–frequency relation on log–log axes. In (a), the horizontal dashed line marks 90% coverage and the vertical dashed line the number of profiles (2199) needed to reach it.
  • Review
  • Open Access

Beyond Genomic Alterations: Transcriptomic Profiling of Lineage Plasticity in Metastatic Solid Tumors

  • Maria Concetta Nigro,
  • Margherita Nannini and
  • Annalisa Astolfi
  • + 1 author

Lineage plasticity allows tumor cells to shift their differentiation state during metastatic progression and treatment. Genomic profiling identifies driver alterations and clonal relationships but does not fully characterize the lineage programs expressed by metastatic lesions. This review examines the complementary role of transcriptomic profiling and histopathology in assessing changes in tumor identity, with emphasis on colorectal, pancreatic, prostate, and lung cancers. We discuss studies of lineage transformation, intermediate cellular states, and loss of lineage fidelity, and their relationship to metastatic progression and therapeutic resistance. Bulk, single-cell, single-nucleus, and spatial transcriptomic approaches provide information on malignant-cell differentiation, intratumoral heterogeneity, and microenvironmental context. Integrating these findings with morphology, immunohistochemistry, and genomic analysis may support the development of biomarkers that characterize metastatic cell states and identify programs associated with resistance. By synthesizing these findings, this review aims to clarify how RNA profiling may complement genomic and histopathological assessment of metastatic tumor identity. It also explores how lineage-associated programs could inform diagnostic biomarkers and therapeutic strategies, including modification of plastic states or targeting of their acquired dependencies. The review discusses the analytical and clinical evaluation needed to connect these biological findings with the assessment of metastatic biopsies.

Diagnostics

18 November 2026

Lineage plasticity and integrated assessment of metastatic tumor identity. Tumor cells may retain shared genomic alterations while acquiring different transcriptional programs and phenotypic states. Therapy, microenvironmental signals and epigenetic reprogramming may contribute to these changes. Neuroendocrine-like, basal/squamous-like and regenerative/fetal-like states are illustrative examples observed in different tumor contexts; the arrows do not represent a universal or obligatory trajectory. The indicated markers are examples of phenotype-associated markers and require interpretation within the relevant histopathological context. Integrating DNA profiling, RNA profiling and histopathology may support the characterization of metastatic tumor identity. Abbreviations: CHGA, chromogranin A; KRT5, keratin 5; SYP, synaptophysin; TP63, tumor protein p63. Created using R (version 4.6.1).
  • Article
  • Open Access

Background/Objectives: When unidentified remains lack an ante-mortem record, relatives may be prioritised for DNA testing. Panoramic radiographs (OPGs) are routine dental records, but kinship models can exploit age or acquisition differences. We tested whether calibrated likelihood ratios (LRs) from paired OPGs can rank candidate relatives before DNA testing. Methods: Using 1117 single-centre OPGs of living patients from 560 sibling pairs confirmed by telephone (174 dizygotic twin pairs), eleven verification methods and three fusion models were evaluated by family-disjoint cross-validation against negatives matched for age, sex composition and acquisition signature. An exploratory analysis estimated sibling intraclass correlations (ICC) of 70 automatically measured phenotypes; automated tooth dimensions were compared with blinded manual measurements in 60 radiographs. Results: The primary fusion model had an AUC of 0.516 (95% CI 0.482–0.551) and a log likelihood ratio cost of 1.009; no fusion model, twin or age stratum differed from chance. Age difference alone gave an AUC of 0.778 against unmatched negatives, and adding the fusion score did not improve it. Automated tooth lengths exceeded manual lengths by 36%. Vertical tooth and mandibular dimensions resembled each other within families (held-out ICC 0.269, 95% CI 0.200–0.334), yet a Gaussian LR model gave an AUC of 0.563 and a median LR near 1.03. Conclusions: In this sample, apparent sibling discrimination on OPGs was largely explained by age. A familial resemblance was detectable, but none of the evaluated models showed evidential value, so they should not be used to prioritise relatives. Other populations, measurement methods and post-mortem radiographs were not tested.

Diagnostics

18 November 2026

Study flow and analysis structure. Folds were pre-assigned and kept every family and linked family group within one fold; for test fold k, fold (k + 1) mod 5 served for calibration and the other three folds for training.

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Diagnostics - ISSN 2075-4418